Browse Category

Insider Trading News 29 December 2025 - 30 December 2025

Lionsgate Studios (LION) stock slides today after insider sales hit the tape

Lionsgate Studios (LION) stock slides today after insider sales hit the tape

NEW YORK, December 30, 2025, 13:49 ET — Regular session Lionsgate Studios Corp shares fell 3.4% on Tuesday, retreating after filings showed two top executives sold stock late this month. The stock was down 32.5 cents at $9.105, after trading between $9.06 and $9.45. The disclosures landed with the stock near the top of its 52-week range of $5.55 to $9.46. That has made the name more sensitive to any sign of selling pressure heading into year-end. StockAnalysis Form 4 filings — mandatory SEC reports that disclose insider buying and selling — can move shares in the short term because
Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

Edgewise Therapeutics stock steady midday after $3 million insider sale filing — what’s next for EWTX

NEW YORK, December 30, 2025, 12:33 ET — Regular session Edgewise Therapeutics shares were up 0.2% at $24.68 as of 12:18 p.m. ET on Tuesday, after a Form 144 filing showed company officer Robert Michael Carruthers sold 116,665 shares worth about $3.04 million on Dec. 26. The stock traded between $24.40 and $24.92. SEC The disclosure matters because Edgewise is a development-stage biotech, where trading often centers on clinical milestones and cash runway rather than product sales. Insider transactions can draw outsized attention after sharp moves, even when the dollar amounts are modest. Biotech stocks also lagged, with the iShares
CoreWeave stock edges higher after insider-sale filings; what CRWV investors are watching next

CoreWeave stock edges higher after insider-sale filings; what CRWV investors are watching next

NEW YORK, December 30, 2025, 12:16 ET — Regular session CoreWeave (CRWV) shares inched higher on Tuesday after late Monday regulatory filings disclosed stock sales tied to a senior executive and director. The disclosures matter because CoreWeave remains a high-volume, high-volatility AI infrastructure name, and investors have been closely tracking insider selling and financing as the company scales data center capacity. Insider trades can sway sentiment in companies like CoreWeave that require heavy upfront spending, especially after the firm warned earlier this quarter that a third-party data center delay would pressure its outlook. The Nasdaq-listed shares were up about 0.5%
AST SpaceMobile insider buy grabs attention as BlueBird 6 satellite rollout heats up Starlink race

AST SpaceMobile insider buy grabs attention as BlueBird 6 satellite rollout heats up Starlink race

NEW YORK, December 30, 2025, 10:25 ET AST SpaceMobile director Keith Larson bought 625 shares of the company’s Class A stock at $80 apiece, according to a Form 4 filing dated Dec. 29. The filing said the transaction was executed under a Rule 10b5-1 plan — a pre-arranged trading plan — and left Larson with 2,015 shares held indirectly through an IRA. SEC The purchase lands as investors watch whether AST can turn its “direct-to-device” pitch into paying service. The term refers to connecting ordinary phones to satellites without special hardware, extending coverage where cell towers don’t reach. AT&T has
Oracle stock rises as Fed minutes near; insider sale notice adds to OpenAI scrutiny

Oracle stock rises as Fed minutes near; insider sale notice adds to OpenAI scrutiny

NEW YORK, December 30, 2025, 10:29 ET — Regular session Oracle shares rose 0.8% to $197.03 in morning trading on Tuesday, recovering after a 1.3% slide in the prior session. MarketWatch The move matters because Oracle is trading like a rate-sensitive, high-valuation software name, with investors using macro signals to price long-dated growth. Minutes from the Fed’s last policy meeting are expected later Tuesday, a potential catalyst for bond yields and tech multiples. Oracle has also become a flashpoint in the market debate over AI infrastructure spending, as investors weigh whether surging demand justifies heavy upfront buildouts. Capital expenditures, or
Planet Labs stock rises on Clear Street $22 target hike as insider sale notices surface

Planet Labs stock rises on Clear Street $22 target hike as insider sale notices surface

NEW YORK, December 30, 2025, 02:00 ET — Market closed. Planet Labs PBC shares rose 2.7% to $19.87 at Monday’s close after Clear Street raised its price target on the satellite-imagery company to $22 from $16 and maintained a Buy rating. The brokerage pointed to growth potential as Planet pairs its imagery with AI-driven analytics and said it sees a path to the “Rule of 40” benchmark — where revenue growth plus EBITDA margin equals 40 — by fiscal 2028. The stock traded between $18.75 and $20.13 and is near a 52-week high of $20.99. Investing.com Canada The call matters
Baidu stock today: BIDU rises as insider sale filing surfaces, with Fed minutes next

Baidu stock today: BIDU rises as insider sale filing surfaces, with Fed minutes next

NEW YORK, December 30, 2025, 00:50 ET — Market closed Baidu, Inc.’s U.S.-listed shares closed up 1.6% at $126.81 on Monday. A U.S. securities filing showed Baidu officer Wang Haifeng proposed selling 50,000 American depositary shares (ADS), worth about $6.24 million, after a same-day cashless option exercise and restricted-share vesting under company incentive plans. SEC The disclosure hit tape as U.S. markets turned more cautious, with Wall Street’s main indexes ending lower on Monday after a pullback in heavyweight technology shares. “This is (not) the beginning of the end of the tech dominance,” said Hank Smith, head of investment strategy
Palo Alto Networks stock dips as insider sales hit SEC filings; Fed minutes next

Palo Alto Networks stock dips as insider sales hit SEC filings; Fed minutes next

NEW YORK, December 29, 2025, 10:55 PM ET — Market closed Palo Alto Networks, Inc. (PANW) shares slipped 0.8% on Monday and closed at $186.85, after trading between $186.23 and $188.97. The disclosures matter in year-end trading, when liquidity can be thinner and investors react faster to new filings. The stock also trades as a high-growth software name, which can make it sensitive to shifts in interest-rate expectations. A filing showed chief financial officer Dipak Golechha sold 5,000 shares on Dec. 23 at $188.182 per share, leaving him with 155,119 shares. The filing said the sale was made under a
Nebius (NBIS) stock slips after insider sale notices hit SEC filings in thin year-end trade

Nebius (NBIS) stock slips after insider sale notices hit SEC filings in thin year-end trade

NEW YORK, December 29, 2025, 19:45 ET — After-hours Nebius Group N.V. shares slid on Monday after SEC filings showed founder Arkady Volozh and two other insiders planned share sales around year-end. The stock was down 1.8% at $86.04 in late trade. SEC+2SEC+2 The notices matter now because NBIS has been a high-beta trade — a stock that tends to swing more than the market — and additional supply can weigh on prices when liquidity is thin in the final days of the year. The filings landed as U.S. stocks dipped broadly, with the Nasdaq ending down 0.5%. “We’re seeing
Disney shares edge up as investors digest insider sale notice in thin year-end trade

Disney shares edge up as investors digest insider sale notice in thin year-end trade

NEW YORK, December 29, 2025, 12:56 PM ET — Regular session. Shares of The Walt Disney Company rose slightly on Monday as investors navigated thin year-end trading and weighed a new disclosure showing a small insider stock sale tied to equity compensation. Disney shares were up about 0.4% at $114.02 in midday New York trade. The day’s move came as U.S. stock-index futures softened ahead of the final stretch of 2025, with investors still watching whether the market can extend the so-called “Santa Claus rally” into early January. Investors Disney disclosed on Monday that Sonia Coleman, listed as an officer,
Oracle stock slips after insider sale filing as OpenAI-linked spending stays in focus

Oracle stock slips after insider sale filing as OpenAI-linked spending stays in focus

NEW YORK, December 29, 2025, 09:56 ET — Regular session Oracle shares fell 0.4% to $197.27 in early trading on Monday after a company officer disclosed a planned share sale, with investors still wary about the cost of the software maker’s push to expand AI-related cloud capacity. The filing matters because Oracle has become a touchstone for a broader market question: how much debt and spending big tech can absorb as demand for AI computing accelerates, especially heading into year-end when liquidity can thin and moves can get exaggerated. Benzinga That scrutiny has been sharpest around Oracle’s ties to privately
Ondas stock slides after insider-sale filings, with January order timeline in focus

Ondas stock slides after insider-sale filings, with January order timeline in focus

NEW YORK, December 29, 2025, 02:26 ET — Market closed Ondas Holdings shares ended down 7.12% at $8.48 in the latest session on Friday, a sharp pullback in a stock that has swung widely in December. Investing.com The move matters because traders have been parsing a burst of insider-transaction disclosures alongside Ondas’ push to bundle drones, ground robots and counter-drone systems, areas that can drive abrupt sentiment shifts in smaller stocks. Ondas Holdings Inc.+2Ondas Holdings Inc.+2 With U.S. markets set to reopen into a week packed with economic data and Treasury bill auctions, investors are also watching whether risk appetite
1 15 16 17 18 19 28

Stock Market Today

GSK share price set for Monday watch after EU clears Nucala COPD use

GSK share price set for Monday watch after EU clears Nucala COPD use

7 February 2026
GSK shares closed Friday up 0.83% at a 52-week high after the EU approved Nucala for certain uncontrolled COPD patients. Insider filings showed chairman Jonathan Symonds bought 2,500 shares while executive David Redfern sold 100,000. The FTSE 100 rose 0.6%. Broker ratings on GSK remained mixed.
Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

Aye Finance IPO: Rs 454-crore anchor haul follows valuation cut below last round

7 February 2026
Aye Finance raised Rs 454.5 crore from 19 anchor investors ahead of its Feb 9 IPO, pricing shares at the top of a Rs 122–129 range. The company’s profit fell 40% to Rs 64.3 crore in the six months to September as bad loans rose to 4.85%. The IPO values Aye at about Rs 3,200 crore, below its last private round. Major investors include Nippon Life India and Goldman Sachs funds.
BAT share price closes near 52-week high as buyback rolls on ahead of results week

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
British American Tobacco shares closed up 1.2% at 4,609 pence Friday, near a 52-week high. The company disclosed further share buybacks and management share purchases ahead of its Feb. 12 full-year results. BAT bought 121,668 shares for cancellation on Feb. 5. Investors await updates on nicotine alternatives and cash returns.
Go toTop